The upper normal limit of serum alanine aminotransferase in Golestan Province, Northeast Iran

Archives of Iranian Medicine

Volumn 11, Issue 6, 2008, Pages 602-607

  Jamali, Raika ^a   Pourshams, Akram ^a   Amini, Sedighe ^b   Deyhim, Mohammad Reza ^b   Rezvan, Houri ^b   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Alanine aminotransferase; Body mass index; Gender; General population; Upper normal limit

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRINKING BEHAVIOR; FEMALE; HUMAN; HYPERPHENYLALANINEMIA; IRAN; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; POPULATION RESEARCH; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; BLOOD GLUCOSE; BODY MASS INDEX; CHEMISTRY, CLINICAL; DIABETES MELLITUS; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 57449105072     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000; 342: 1266-1271.
2. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004; 328: 983.
3. Karmen A, Wroblewski F, LaDue JS. Transaminase activity in human blood. J Clin Invest. 1955; 34: 126-133.
4. Orabona ML, Filotico M, Micelli O. Relation between transaminase activity of the blood and histological picture of the liver in human hepatic pathology. Minerva Med. 1958; 49: 4292-4295.
5. Kallei L, Hahn A, Roder VZ. Correlation between histological findings and serum transaminase values in chronic diseases of the liver. Acta Medica Scandinavika. 1964; 175: 49-56.
6. Kahn RA, Johnson G, Aach RD, Hines A, Ellis FR, Miller WV. The distribution of serum alanine aminotransferase levels in a blood donor population. Am J Epidemiol. 1982; 115: 929-940.
7. Grunenberg R, Banik N, Kruger J. Alanine aminotransferase (ALAT, GPT): a re-evaluation of exclusion limits for blood donors. Infusionsther Transfusionsmed. 1995; 22: 145-151.
8. Lozano M, Cid J, Bedini JL, Mazzara R, Gimenez N, Mas E, et al. Study of serum alanine-aminotransferase levels in blood donors in Spain. Haematologica. 1998; 83: 237-239.
9. Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol. 1999; 94: 3010-3014.
10. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 1997; 126: 137-145.
11. Hay JE, Czaja AJ, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology. 1989; 9: 193-197.
12. Mohamadnejad M, Pourshams A, Malekzadeh R, Mohamadkhani A, Rajabiani A, Asgari AA, et al. Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World J Gastroentrol. 2003; 9: 2322-2324.
13. Kariv R, Leshno M, Beth-Or A, Strul H, Blendis L, Kokia E, et al. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int. 2006; 26: 445-450.
14. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002; 137: 1-10.
15. US Department of Health and Human Services. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Washington, DC: US Department of Health and Human Services; 1998:15.
16. Nakamura K, Okamura T, Kanda H, Hayakawa T, Okayama A, Ueshima H. The value of combining serum alanine aminotransferase levels and body mass index to predict mortality and medical costs: a 10-year follow-up study of National Health Insurance in Shiga, Japan. J Epidemiol. 2006; 16: 15-20.
17. Malekzadeh R, Mohamadnejad M, Merat S, Pourshams A. Obesity pandemic: an Iranian perspective. Arch Iran Med. 2005; 8: 1-7.
18. Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S, et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health. 2006; 6: 158.
19. Iacobellis G, Moschetta A, Buzzetti R, Ribaudo MC, Baroni MG, Leonetti F. Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin. Nutr Metab Cardiovasc Dis. 2007; 17: 442-447.
20. Iacobellis G, Moschetta A, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Normal serum alanine aminotransferase activity in uncomplicated obesity. World J Gastroenterol. 2005; 11: 6018-6021.
21. Liu CM, Tung TH, Liu JH, Chen VT, Lin CH, Hsu CT, et al. A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan. World J Gastroenterol. 2005; 11: 1616-1622.
22. Lee DH, Ha MH, Christiani DC. Body weight, alcohol consumption, and liver enzyme activity. Int J Epidemiol. 2001; 30: 766-770.
23. Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem. 1991; 37: 720-723.
24. Choi JW. Association between elevated serum hepatic enzyme activity and total body fat in obese humans. Ann Clin Lab Sci. 2003; 33:257-264.
25. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology. 1998; 27: 1213-1219.
26. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohamadkhani A, Yarahmadi S, et al. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol. 2005; 20: 229-233.
27. Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram- Kalhori A, et al. Persistant alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol. 2008; 14: 2867-2871.
28. Amini M, Afshin-Nia F, Bashardoost N, Aminorroaya A, Shahparian M, Kazemi M. Prevalence and risk factors of diabetes mellitus in the Isfahan City population (aged 40 or over) in 1993. Diabetes Res Clin Pract. 1997; 38: 185-190.
29. Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, et al. Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care. 2006; 29: 226-231.
30. Ajlouni K, Khader YS, Batieha A, Ajlouni H, El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complications. 2008; 22: 317-324.